Cargando…

Immunology and Immune Checkpoint Inhibition in Ovarian Cancer – Current Aspects

In the last decade immunotherapies such as immune checkpoint blockade (ICB) against the PD-1/PD-L1 system have revolutionised the treatment of numerous entities. To date, ovarian cancer has benefited very little from this success story. Possible causes include a rather low mutational burden compared...

Descripción completa

Detalles Bibliográficos
Autor principal:	Bronger, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494520/ https://www.ncbi.nlm.nih.gov/pubmed/34629492 http://dx.doi.org/10.1055/a-1475-4335

Ejemplares similares

The role of immune checkpoint inhibition in the treatment of ovarian cancer
por: Gaillard, Stéphanie L., et al.
Publicado: (2016)

Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors
por: Pawłowska, Anna, et al.
Publicado: (2023)

Immunologic aspect of ovarian cancer and p53 as tumor antigen
por: Nijman, HW, et al.
Publicado: (2005)

Identification of Novel Immunologic Checkpoint Gene Prognostic Markers for Ovarian Cancer
por: Huo, Xiao, et al.
Publicado: (2022)

Immune Checkpoint Molecules in Reproductive Immunology
por: Miko, Eva, et al.
Publicado: (2019)

The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer
por: Xu, Yufei, et al.
Publicado: (2022)

Cerebral Malaria: Current Clinical and Immunological Aspects
por: Albrecht-Schgoer, Karin, et al.
Publicado: (2022)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

Immune Checkpoint Blockers and Ovarian Cancer
por: Bose, Chinmoy K
Publicado: (2017)

Osteoporosis: Current and Emerging Therapies Targeted to Immunological Checkpoints
por: De Martinis, Massimo, et al.
Publicado: (2020)

Configuring Therapeutic Aspects of Immune Checkpoints in Lung Cancer
por: Khadela, Avinash, et al.
Publicado: (2023)

Immunotherapeutic and their immunological aspects: Current treatment strategies and agents
por: Jain, Mayank, et al.
Publicado: (2022)

Immune checkpoints, their control by immunotherapy and ovarian cancer
por: Bose, Chinmoy K.
Publicado: (2017)

CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
por: Bronger, Holger, et al.
Publicado: (2016)

Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer
por: Ding, Yi, et al.
Publicado: (2022)

CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer
por: Seitz, Stefanie, et al.
Publicado: (2022)

Molecular Aspects of Renal Immunology: Current Status and Future Perspectives
por: Eleftheriadis, Theodoros, et al.
Publicado: (2022)

Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma
por: Foy, Victoria, et al.
Publicado: (2023)

Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer
por: Indini, Alice, et al.
Publicado: (2021)

How to use immune checkpoint inhibitor in ovarian cancer?
por: Park, Junsik, et al.
Publicado: (2019)

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
por: Jung, Chi Young, et al.
Publicado: (2018)

Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
por: Yi, Huimei, et al.
Publicado: (2021)

Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence
por: Stonesifer, Connor J., et al.
Publicado: (2021)

Clinical aspects of immunology /
Publicado: (1993)

Immunological aspects of radiotherapy
por: Scheithauer, Heike, et al.
Publicado: (2014)

Immunological Aspects of Chytridiomycosis
por: Grogan, Laura F., et al.
Publicado: (2020)

Immunological aspects of foods
por: Catsimpoolas, Nicholas
Publicado: (1977)

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
por: Zhao, Binghao, et al.
Publicado: (2022)

Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy
por: Mahmoud, Abdurraouf Mokhtar, et al.
Publicado: (2023)

Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?
por: Musacchio, L., et al.
Publicado: (2022)

Current Status of Immune Checkpoint Inhibitors in Gastrointestinal Cancers
por: Kim, Bum Jun, et al.
Publicado: (2017)

Systemic immunological biomarkers of clinical responses in immune checkpoint blockade therapies
por: Arasanz, Hugo, et al.
Publicado: (2018)

Immunologic Aspects of Dyslipidemia: a Critical Regulator of Adaptive Immunity and Immune Disorders
por: Kim, Daehong, et al.
Publicado: (2021)

Immune Checkpoint Inhibition in Head and Neck Cancer
por: Forster, Martin David, et al.
Publicado: (2018)

Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer
por: Bidnur, S., et al.
Publicado: (2016)

Immunological Aspect of Radiation-Induced Pneumonitis, Current Treatment Strategies, and Future Prospects
por: Kainthola, Anup, et al.
Publicado: (2017)

Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
por: Kabacaoglu, Derya, et al.
Publicado: (2018)

Checkpoint Genes at the Cancer Side of the Immunological Synapse in Bladder Cancer
por: Dobosz, Paula, et al.
Publicado: (2019)

Immunological Aspects of Isolation and Confinement
por: Ponomarev, Sergey, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ionp07h4emiemfggdi3f1g7mev